Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Purohit HS"'
Autor:
Yu M; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States., Zhou D; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States., Oberoi HS; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States., Salem AH; Clinical Pharmacy, Ain Shams University, Cairo, Egypt; Clinical Pharmacology, AbbVie Inc., North Chicago, IL, USA., McKee LA; Process Research and development, Technical Operations, AbbVie Inc., North Chicago, IL, USA., Arnholt JR; Small molecule CMC development, Analytical Research and Development, AbbVie Inc., North Chicago, IL, USA., Purohit HS; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States. Electronic address: hitesh.purohit@abbvie.com., Law D; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States. Electronic address: devalina.law@abbvie.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2025 Jan; Vol. 114 (1), pp. 383-393. Date of Electronic Publication: 2024 Oct 18.
Autor:
Taylor LS; Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States. Electronic address: lstaylor@purdue.edu., Trasi NS; Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States., Purohit HS; Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States; Small molecule CMC development, R&D, AbbVie Inc, North Chicago, IL 60064, United States., Sun D; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, United States., Kinjo M; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, United States., Ni Z; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, United States., Mahjabeen S; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, United States., Feng KK; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, United States., Sun WJ; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, United States., Matta MK; Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA, Silver Spring, MD 20993, United States., Decker B; Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN 46202, United States., Galinsky RE; Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2025 Jan; Vol. 114 (1), pp. 313-322. Date of Electronic Publication: 2024 Oct 15.
Autor:
Alhalaweh A; College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; Department of Pharmacy, Uppsala University, Biomedical Centre, Uppsala, Sweden. Electronic address: aalhalaweh@sharjah.ac.ae., Indulkar AS; Small Molecule CMC Development, Research & Development, AbbVie Inc., North Chicago, IL, USA., Mosquera-Giraldo LI; Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Princeton, NJ, USA., Purohit HS; Small Molecule CMC Development, Research & Development, AbbVie Inc., North Chicago, IL, USA., Raina SA; Hepatology & Virology, International Medical Affairs, AbbVie Inc., North Chicago, IL, USA., Trasi NS; Material Science and Engineering, Drug Product Development, Bristol-Myers Squibb, Summit, NJ, USA., Wikström H; Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2025 Jan; Vol. 114 (1), pp. 265-268. Date of Electronic Publication: 2024 Sep 17.
Autor:
Purohit HS; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL, USA. Electronic address: Hitesh.purohit@abbvie.com., Zhou D; Small Molecule Drug Product Development, BeiGene, Beijing, China., Yu M; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL, USA., Zaroudi M; MilliporeSigma, Temecula, CA, USA., Oberoi H; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL, USA., López ALR; NBE, Drug Product Development, AbbVie Inc., North Chicago, IL, USA., Kelkar MS; Small molecule CMC development, Process Engineering, AbbVie Inc., North Chicago, IL, USA., He Y; Small molecule CMC development, Analytical Research and Development, AbbVie Inc., North Chicago, IL, USA., Gates B; Small molecule CMC development, Process Chemistry, AbbVie Inc., North Chicago, IL, USA., Nere N; Small molecule CMC development, Process Engineering, AbbVie Inc., North Chicago, IL, USA., Law D; Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL, USA. Electronic address: Devalina.law@abbvie.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Apr; Vol. 113 (4), pp. 1007-1019. Date of Electronic Publication: 2023 Oct 11.
Autor:
Yang R; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN, 47907, USA., Zhang GGZ; Development Sciences, Research and Development, AbbVie Inc., North Chicago, IL, 60064, USA., Zemlyanov DY; Birck Nanotechnology Center, Purdue University, West Lafayette, IN, 47907, USA., Purohit HS; Development Sciences, Research and Development, AbbVie Inc., North Chicago, IL, 60064, USA. hitesh.purohit@abbvie.com., Taylor LS; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN, 47907, USA. lstaylor@purdue.edu.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Dec; Vol. 40 (12), pp. 2817-2845. Date of Electronic Publication: 2023 Apr 13.
Autor:
Yu M; Research & Development, AbbVie Inc., North Chicago, Illinois 60064, United States., Oberoi HS; Research & Development, AbbVie Inc., North Chicago, Illinois 60064, United States., Purohit HS; Research & Development, AbbVie Inc., North Chicago, Illinois 60064, United States., Fowler CA; Research & Development, AbbVie Inc., North Chicago, Illinois 60064, United States., Law D; Research & Development, AbbVie Inc., North Chicago, Illinois 60064, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2023 Nov 06; Vol. 20 (11), pp. 5827-5841. Date of Electronic Publication: 2023 Oct 24.
Dissolution Mechanisms of Amorphous Solid Dispersions: Role of Drug Load and Molecular Interactions.
Autor:
Deac A; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana47907, United States., Qi Q; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana47907, United States., Indulkar AS; Development Sciences, Research and Development, AbbVie Inc, North Chicago, Illinois60064, United States., Purohit HS; Development Sciences, Research and Development, AbbVie Inc, North Chicago, Illinois60064, United States., Gao Y; Development Sciences, Research and Development, AbbVie Inc, North Chicago, Illinois60064, United States., Zhang GGZ; Development Sciences, Research and Development, AbbVie Inc, North Chicago, Illinois60064, United States., Taylor LS; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana47907, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2023 Jan 02; Vol. 20 (1), pp. 722-737. Date of Electronic Publication: 2022 Dec 22.
Autor:
Oberoi HS; NCE-Formulation Sciences, AbbVie Inc., North Chicago, IL, USA. Electronic address: hardeep.oberoi@abbvie.com., Arce F; Current Affiliation: Bristol Myers Squibb, NJ, USA., Purohit HS; NCE-Formulation Sciences, AbbVie Inc., North Chicago, IL, USA., Yu M; NCE-Formulation Sciences, AbbVie Inc., North Chicago, IL, USA., Fowler CA; NCE-Formulation Sciences, AbbVie Inc., North Chicago, IL, USA., Zhou D; Current Affiliation: BeiGene, USA., Law D; NCE-Formulation Sciences, AbbVie Inc., North Chicago, IL, USA. Electronic address: Devalina.law@abbvie.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2023 Jan; Vol. 112 (1), pp. 250-263. Date of Electronic Publication: 2022 Oct 13.
Autor:
Purohit HS; Development Sciences, Research and Development, AbbVie Inc., North Chicago, IL, USA., Zhang GGZ; Development Sciences, Research and Development, AbbVie Inc., North Chicago, IL, USA. Electronic address: geoff.gz.zhang@abbvie.com., Gao Y; Development Sciences, Research and Development, AbbVie Inc., North Chicago, IL, USA. Electronic address: gao.yi@abbvie.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2023 Jan; Vol. 112 (1), pp. 290-303. Date of Electronic Publication: 2022 Oct 25.
Autor:
Yang R; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN, 47907, USA., Zhang GGZ; Drug Product Development, AbbVie Inc., North Chicago, IL, 60064, USA., Zemlyanov DY; Birck Nanotechnology Center, Purdue University, West Lafayette, IN, 47907, USA., Purohit HS; Drug Product Development, AbbVie Inc., North Chicago, IL, 60064, USA. Electronic address: hitesh.purohit@abbvie.com., Taylor LS; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN, 47907, USA. Electronic address: lstaylor@purdue.edu.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2023 Jan; Vol. 112 (1), pp. 304-317. Date of Electronic Publication: 2022 Oct 25.